Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04809051 · ClinicalTrials.gov registry record · NA

Don't Throw Your Heart Away: Patient Study 4

A NA study, sponsored by Carnegie Mellon University.

Completed
Registry status
NA
Development phase
94
Enrollment target

NCT04809051 is a NA study that has completed, run by Carnegie Mellon University. The registered enrollment target is 94 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04809051, a NA study, has completed, sponsored by Carnegie Mellon University.

COMPLETED
Registry status
NA
Development phase
94 participants
Enrollment target

Study Summary

This empirical study tests whether transplant center performance data that reflect center donor acceptance rates influence patients and their family members to evaluate centers with high organ decline rates less favorably than centers with low organ decline rates. 400 transplant patients and family members will be recruited from transplant support group social media websites and randomized to one of four different information presentation conditions. Upon viewing a pair of outcome tables corresponding to their condition, the participants are asked to choose which hospital is higher performing (one hospital with a non-selective "accepting" strategy and one hospital with a more selective "cherrypicking" strategy.

Interventions

  • OTHER Stratified Transplant Survival Metric
  • OTHER SRTR Information Format

Trial Details

FieldValue
Enrollment Target 94 participants
Start Date 2021-04-01
Est. Completion 2023-08-31
Phase NA

Sponsor

Carnegie Mellon University

37 total trials

What the Registry Record Tells You About NCT04809051

The ClinicalTrials.gov registry entry for NCT04809051 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Carnegie Mellon University, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Stratified Transplant Survival Metric is the first listed.

NCT04809051 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04809051 about?

NCT04809051 is a clinical study titled "Don't Throw Your Heart Away: Patient Study 4". This empirical study tests whether transplant center performance data that reflect center donor acceptance rates influence patients and their family members to evaluate centers with high organ decline rates less favorably than centers with low organ decline rates. 400 transplant patients and family ...

What is the current status of trial NCT04809051?

This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2021-04-01. Estimated completion is 2023-08-31.

What interventions are being tested in trial NCT04809051?

The interventions under investigation include: Stratified Transplant Survival Metric (OTHER), SRTR Information Format (OTHER).

Who is sponsoring clinical trial NCT04809051?

This trial is sponsored by Carnegie Mellon University, which has 37 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.